HEMATOPOIESIS - BRIEF REPORT Phase I Clinical Study of Eltrombopag, an Oral, Non-peptide Thrombopoietin Receptor Agonist

1. All of the authors (JMJ, DW, YD, JU, VK, DC, CEM) have declared a financial interest in a company whose (potential) product was studied in the present work. 2. Several of the authors (CEM, DC )have declared a financial interest in a competitor of a company whose (potential) product was studied in the present work. 3. All of the authors (JMJ, DW, YD, JU, VK, DC, CEM) are employed by a company or a competitor of a company (X company) whose (potential) product was studied in the present work. 4. Several of the authors (JMJ, CEM) hold a patent related to the work that is described in the present study.